| Title | Therapeutic Advances in Endocrinology and Metabolism |
| Abbreviation | Ther. Adv. Endocrinol. Metab. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology, Diabetes and Metabolism (Q1) |
| h-index | 49 |
| Overall Rank/Ranking | 2769 |
| SCImago Journal Rank (SJR) | 1.381 |
| Impact Score | 4.48 |
| Publisher | Sage Periodicals Press |
| Country | United States |
| ISSN | 20420196, 20420188 |
| Best Quartile | Q1 |
| Coverage History | 2010-2025 |
Therapeutic Advances in Endocrinology and Metabolism is a journal covering the technologies/fields/categories related to Endocrinology, Diabetes and Metabolism (Q1). It is published by Sage Periodicals Press. The overall rank of Therapeutic Advances in Endocrinology and Metabolism is 2769. According to SCImago Journal Rank (SJR), this journal is ranked 1.381. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 49. The best quartile for this journal is Q1.
The ISSN of Therapeutic Advances in Endocrinology and Metabolism journal is 20420196, 20420188. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Endocrinology and Metabolism is cited by a total of 680 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Therapeutic Advances in Endocrinology and Metabolism is 4.48, which is computed in 2025 as per its definition. Therapeutic Advances in Endocrinology and Metabolism IF is increased by a factor of 0.44 and approximate percentage change is 10.89% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Therapeutic Advances in Endocrinology and Metabolism is 4.48. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.48 |
| 2023 | 4.04 |
| 2022 | 3.61 |
| 2021 | 4.13 |
| 2020 | 3.20 |
| 2019 | 2.59 |
| 2018 | 3.62 |
| 2017 | 4.28 |
| 2016 | 3.73 |
| 2015 | 2.57 |
| 2014 | 3.17 |
Therapeutic Advances in Endocrinology and Metabolism has an h-index of 49. It means 49 articles of this journal have more than 49 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Endocrinology and Metabolism is 20420196, 20420188. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Endocrinology and Metabolism is 2769. According to SCImago Journal Rank (SJR), this journal is ranked 1.381. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.381 |
| 2023 | 1.301 |
| 2022 | 1.058 |
| 2021 | 0.922 |
| 2020 | 0.889 |
| 2019 | 0.872 |
| 2018 | 1.049 |
| 2017 | 1.313 |
| 2016 | 0.995 |
| 2015 | 0.687 |
| 2014 | 0.734 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2769 |
| 2023 | 2868 |
| 2022 | 3845 |
| 2021 | 4635 |
| 2020 | 5233 |
| 2019 | 5289 |
| 2018 | 4057 |
| 2017 | 2878 |
| 2016 | 4464 |
| 2015 | 6920 |
| 2014 | 6327 |
Therapeutic Advances in Endocrinology and Metabolism is published by Sage Periodicals Press. It's publishing house is located in United States. Coverage history of this journal is as following: 2010-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Endocrinology and Metabolism is Ther. Adv. Endocrinol. Metab.. This abbreviation ('Ther. Adv. Endocrinol. Metab.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology, Diabetes and Metabolism (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Endocrinology and Metabolism latest impact IF is 4.48. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.48 (2024) and 2.57 (2015), respectively, in the last 11 years. Moreover, its average IS is 3.58 in the previous 11 years.
The Therapeutic Advances in Endocrinology and Metabolism has an SJR (SCImago Journal Rank) of 1.381, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.381 in 2024 and the lowest being 0.687 in 2015. Furthermore, the average SJR of the Therapeutic Advances in Endocrinology and Metabolism over the previous 11-year period stands at 3.58.
The latest h-index of the Therapeutic Advances in Endocrinology and Metabolism is 49.
The Therapeutic Advances in Endocrinology and Metabolism is published by the Sage Periodicals Press, with its country of publication being the United States.
The Therapeutic Advances in Endocrinology and Metabolism is currently ranked 2769 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2769 in 2024 and its lowest position of 6920 in 2015.
The standard ISO4 abbreviation for the Therapeutic Advances in Endocrinology and Metabolism is Ther. Adv. Endocrinol. Metab..
Therapeutic Advances in Endocrinology and Metabolism is classified as a journal that the Sage Periodicals Press publishes.
The Therapeutic Advances in Endocrinology and Metabolism encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Endocrinology and Metabolism is assigned the following International Standard Serial Numbers (ISSN): 20420196, 20420188.
The best quartile for the Therapeutic Advances in Endocrinology and Metabolism is Q1 (2024).
The Therapeutic Advances in Endocrinology and Metabolism coverage history can be summarized as follows: 2010-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| Abacus | journal | 11890 | Wiley-Blackwell Publishing Ltd | 56 | 2.95 |
| Modern Language Journal | journal | 1033 | Wiley-Blackwell | 123 | 3.95 |
| British Journal of Special Education | journal | 14055 | Wiley-Blackwell Publishing Ltd | 45 | 1.43 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Rudarsko Geolosko Naftni Zbornik | journal | 14286 | Faculty of Mining, Geology and Petroleum Engineering University of Zagreb | 22 | 1.78 |
| Psycho-Oncologie | journal | 24496 | Tech Science Press | 12 | 0.35 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.48 |
| 2023 | 4.04 |
| 2022 | 3.61 |
| 2021 | 4.13 |
| 2020 | 3.20 |
| 2019 | 2.59 |
| 2018 | 3.62 |
| 2017 | 4.28 |
| 2016 | 3.73 |
| 2015 | 2.57 |
| 2014 | 3.17 |
